Ryosuke Suzuki

Ryosuke Suzuki

Auto-generated profile, based on publicly available information

Ryosuke Suzuki

Department of Neurosurgery, Japanese Red Cross Asahikawa Hospital, Asahikawa, Hokkaido, Japan; Department of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2022 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Open access
PDF file
TATaisuke Akimoto
Taisuke Akimoto
MOMakoto Ohtake
Makoto Ohtake
SMShigeta Miyake
Shigeta Miyake
RSRyosuke Suzuki
Ryosuke Suzuki
YIYu Iida
Yu Iida
TYTetsuya Yamamoto
Tetsuya Yamamoto
Background Meningiomas are often embolized preoperatively to reduce intraoperative blood loss and facilitate tumor resection. However, the procedure is controversial and its effects have not yet been reported. We evaluated preoperative embolization for meningiomas and its effect on postoperative outcome and recurrence. Methods We retrospectively reviewed the medical records of 186 patients with WHO grade I meningiomas who underwent surgical treatment at our hospital between January 2010 and December 2020. We used propensity score matching to generate embolization and no-embolization groups (42 patients each) to examine embolization effects. Results Preoperative embolization was performed in 71 patients (38.2%). In the propensity-matched analysis, the embolization group showed favorable recurrence-free survival (RFS) (mean 49.4 vs 24.1 months; Wilcoxon p=0.049). The embolization group had significantly less intraoperative blood loss (178±203 mL vs 221±165 mL; p=0.009) and shorter operation time (5.6±2.0 hours vs 6.8±2.8 hours; p=0.036). There were no significant differences in Simpson grade IV resection (33.3% vs 28.6%; p=0.637) or overall perioperative complications (21.4% vs 11.9%; p=0.241). Tumor embolization prolonged RFS in a subanalysis of cases who experienced recurrence (n=39) among the overall cases before variable control (mean RFS 33.2 vs 16.0 months; log-rank p=0.003). Conclusions After controlling for variables, preoperative embolization for meningioma did not improve the Simpson grade or patient outcomes. However, it might have effects outside of surgical outcomes by prolonging RFS without increasing complications.

18 October 2023 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
THTakahiro Hayashi
Takahiro Hayashi
KTKensuke Tateishi
Kensuke Tateishi
SMShinichiro Matsuyama
Shinichiro Matsuyama
HIHiromichi Iwashita
Hiromichi Iwashita
YMYohei Miyake
Yohei Miyake
TYTetsuya Yamamoto
Tetsuya Yamamoto
Purpose: The 2021 World Health Organization (WHO) classification of central nervous system (CNS) tumors uses an integrated approach involving histopathology and molecular profiling. Because majority of adult malignant brain tumors are gliomas and primary CNS lymphomas (PCNSL), rapid differentiation of these diseases is required for therapeutic decisions. In addition, diffuse gliomas require molecular information on single-nucleotide variants (SNV), such as IDH1/2. Here, we report an intraoperative integrated diagnostic (i-ID) system to classify CNS malignant tumors, which updates legacy frozen-section (FS) diagnosis through incorporation of a qPCR-based genotyping assay. Experimental Design: FS evaluation, including GFAP and CD20 rapid IHC, was performed on adult malignant CNS tumors. PCNSL was diagnosed through positive CD20 and negative GFAP immunostaining. For suspected glioma, genotyping for IDH1/2, TERT SNV, and CDKN2A copy-number alteration was routinely performed, whereas H3F3A and BRAF SNV were assessed for selected cases. i-ID was determined on the basis of the 2021 WHO classification and compared with the permanent integrated diagnosis (p-ID) to assess its reliability. Results: After retrospectively analyzing 153 cases, 101 cases were prospectively examined using the i-ID system. Assessment of IDH1/2, TERT, H3F3AK27M, BRAFV600E, and CDKN2A alterations with i-ID and permanent genomic analysis was concordant in 100%, 100%, 100%, 100%, and 96.4%, respectively. Combination with FS and intraoperative genotyping assay improved diagnostic accuracy in gliomas. Overall, i-ID matched with p-ID in 80/82 (97.6%) patients with glioma and 18/19 (94.7%) with PCNSL. Conclusions: The i-ID system provides reliable integrated diagnosis of adult malignant CNS tumors.

31 March 2022 in Surgical Neurology International
Verified
Journal Article
Open access
YMYu Masuko
Yu Masuko
NSNobuyuki Shimizu
Nobuyuki Shimizu
RSRyosuke Suzuki
Ryosuke Suzuki
JSJun Suenaga
Jun Suenaga
KNKagemichi Nagao
Kagemichi Nagao
TYTetsuya Yamamoto
Tetsuya Yamamoto
Background: It is not well-known that contralateral vertebral artery dissecting aneurysms (VADA) may be newly revealed after parental artery occlusion for unilateral VADA. However, the optimal treatment strategies and perioperative management have not been established. In this report, we present the case of a patient who required reconstructive embolization in the subacute stage for contralateral VADA developed after endovascular internal trapping of the ruptured VADA. Case Description: A 61-year-old man developed subsequent disturbance of consciousness. Head CT showed a diffuse and symmetrical SAH. 3DCT revealed a fusiform aneurysm of the left intracranial vertebral artery with bleb formation. We performed emergency endovascular parent artery occlusion of the left vertebral artery. A digital subtraction angiography on postoperative day 16 showed continued occlusion of the left VA, and a fusiform aneurysm was noted at the right VA. We performed reconstructive embolization and the patient eventually recovered with minimal persistent symptoms. Conclusion: Since the outcomes of contralateral VAD complicated by infarction or hemorrhage are poor, and most cases develop within 7–14 days after endovascular internal trapping for unilateral VAD, performing bilateral radiographic reinspection within this time frame is recommended for early detection and preventive treatment of possible contralateral VADs.

5 January 2024
Verified
Other
Open access
PDF file
THTakahiro Hayashi
Takahiro Hayashi
KTKensuke Tateishi
Kensuke Tateishi
SMShinichiro Matsuyama
Shinichiro Matsuyama
HIHiromichi Iwashita
Hiromichi Iwashita
YMYohei Miyake
Yohei Miyake
TYTetsuya Yamamoto
Tetsuya Yamamoto
Illustrative cases in the retrospective cohort

5 January 2024
Verified
Other
Open access
PDF file
THTakahiro Hayashi
Takahiro Hayashi
KTKensuke Tateishi
Kensuke Tateishi
SMShinichiro Matsuyama
Shinichiro Matsuyama
HIHiromichi Iwashita
Hiromichi Iwashita
YMYohei Miyake
Yohei Miyake
TYTetsuya Yamamoto
Tetsuya Yamamoto
Mismatch ratio for genomic alterations in the retrospective cohort

5 January 2024
Verified
Other
Open access
PDF file
THTakahiro Hayashi
Takahiro Hayashi
KTKensuke Tateishi
Kensuke Tateishi
SMShinichiro Matsuyama
Shinichiro Matsuyama
HIHiromichi Iwashita
Hiromichi Iwashita
YMYohei Miyake
Yohei Miyake
TYTetsuya Yamamoto
Tetsuya Yamamoto
Illustrative mismatch cases in the prospective cohort